AERI Annual FCF
-$102.44 M
-$34.66 M-51.12%
31 December 2021
Summary:
As of January 23, 2025, AERI annual free cash flow is -$102.44 million, with the most recent change of -$34.66 million (-51.12%) on December 31, 2021. During the last 3 years, it has risen by +$81.44 million (+44.29%).AERI Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AERI Quarterly FCF
-$12.21 M
+$2.39 M+16.35%
30 September 2022
Summary:
As of January 23, 2025, AERI quarterly free cash flow is -$12.21 million, with the most recent change of +$2.39 million (+16.35%) on September 30, 2022. Over the past year, it has increased by +$7.80 million (+38.97%).AERI Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AERI TTM FCF
$2.64 M
+$7.80 M+151.08%
30 September 2022
Summary:
As of January 23, 2025, AERI TTM free cash flow is $2.64 million, with the most recent change of +$7.80 million (+151.08%) on September 30, 2022. Over the past year, it has increased by +$52.45 million (+105.29%).AERI TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AERI Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -51.1% | +39.0% | +105.3% |
| 3 y3 years | +44.3% | +68.7% | +101.6% |
| 5 y5 years | +6.2% | +52.6% | +101.6% |
AERI Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | +750.4% | -120.3% | at high |
Aerie Pharmaceuticals Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | -$12.21 M(-16.4%) | $2.64 M(-151.1%) |
| June 2022 | - | -$14.60 M(-124.2%) | -$5.16 M(-54.3%) |
| Mar 2022 | - | $60.31 M(-295.4%) | -$11.30 M(-89.0%) |
| Dec 2021 | -$102.44 M(+51.1%) | -$30.86 M(+54.2%) | -$102.44 M(+105.6%) |
| Sept 2021 | - | -$20.01 M(-3.5%) | -$49.82 M(-6.0%) |
| June 2021 | - | -$20.75 M(-32.7%) | -$52.98 M(-4.6%) |
| Mar 2021 | - | -$30.83 M(-241.6%) | -$55.55 M(-18.0%) |
| Dec 2020 | -$67.79 M(-57.7%) | $21.77 M(-193.9%) | -$67.79 M(-42.9%) |
| Sept 2020 | - | -$23.17 M(-0.6%) | -$118.73 M(-11.8%) |
| June 2020 | - | -$23.32 M(-45.8%) | -$134.54 M(-10.2%) |
| Mar 2020 | - | -$43.06 M(+47.6%) | -$149.87 M(-6.6%) |
| Dec 2019 | -$160.39 M(-12.8%) | -$29.17 M(-25.2%) | -$160.39 M(-2.6%) |
| Sept 2019 | - | -$38.99 M(+0.9%) | -$164.64 M(-6.1%) |
| June 2019 | - | -$38.65 M(-27.9%) | -$175.28 M(-6.5%) |
| Mar 2019 | - | -$53.58 M(+60.3%) | -$187.51 M(+2.0%) |
| Dec 2018 | -$183.89 M(+68.4%) | -$33.42 M(-32.7%) | -$183.89 M(-0.9%) |
| Sept 2018 | - | -$49.63 M(-2.4%) | -$185.51 M(+14.8%) |
| June 2018 | - | -$50.87 M(+1.8%) | -$161.63 M(+21.2%) |
| Mar 2018 | - | -$49.96 M(+42.6%) | -$133.39 M(+22.2%) |
| Dec 2017 | -$109.18 M | -$35.05 M(+36.1%) | -$109.18 M(+12.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2017 | - | -$25.76 M(+13.9%) | -$96.67 M(+3.9%) |
| June 2017 | - | -$22.62 M(-12.2%) | -$93.01 M(+2.2%) |
| Mar 2017 | - | -$25.76 M(+14.3%) | -$90.98 M(+7.1%) |
| Dec 2016 | -$84.92 M(+43.9%) | -$22.53 M(+2.0%) | -$84.92 M(+8.8%) |
| Sept 2016 | - | -$22.09 M(+7.3%) | -$78.05 M(+13.6%) |
| June 2016 | - | -$20.60 M(+4.6%) | -$68.68 M(+5.9%) |
| Mar 2016 | - | -$19.69 M(+25.8%) | -$64.87 M(+9.9%) |
| Dec 2015 | -$59.03 M(+74.1%) | -$15.66 M(+23.1%) | -$59.03 M(+7.8%) |
| Sept 2015 | - | -$12.73 M(-24.2%) | -$54.73 M(+6.1%) |
| June 2015 | - | -$16.79 M(+21.3%) | -$51.57 M(+19.3%) |
| Mar 2015 | - | -$13.85 M(+21.8%) | -$43.23 M(+27.5%) |
| Dec 2014 | -$33.91 M(+105.4%) | -$11.37 M(+18.9%) | -$33.91 M(+23.5%) |
| Sept 2014 | - | -$9.56 M(+13.1%) | -$27.45 M(+25.4%) |
| June 2014 | - | -$8.45 M(+86.8%) | -$21.90 M(+17.4%) |
| Mar 2014 | - | -$4.53 M(-8.0%) | -$18.65 M(+13.0%) |
| Dec 2013 | -$16.51 M(+9.9%) | -$4.92 M(+22.9%) | -$16.51 M(+42.4%) |
| Sept 2013 | - | -$4.00 M(-23.2%) | -$11.59 M(+52.7%) |
| June 2013 | - | -$5.21 M(+118.4%) | -$7.59 M(+218.4%) |
| Mar 2013 | - | -$2.38 M | -$2.38 M |
| Dec 2012 | -$15.02 M(+24.7%) | - | - |
| Dec 2011 | -$12.05 M | - | - |
FAQ
- What is Aerie Pharmaceuticals annual free cash flow?
- What is the all time high annual FCF for Aerie Pharmaceuticals?
- What is Aerie Pharmaceuticals annual FCF year-on-year change?
- What is Aerie Pharmaceuticals quarterly free cash flow?
- What is the all time high quarterly FCF for Aerie Pharmaceuticals?
- What is Aerie Pharmaceuticals quarterly FCF year-on-year change?
- What is Aerie Pharmaceuticals TTM free cash flow?
- What is the all time high TTM FCF for Aerie Pharmaceuticals?
- What is Aerie Pharmaceuticals TTM FCF year-on-year change?
What is Aerie Pharmaceuticals annual free cash flow?
The current annual FCF of AERI is -$102.44 M
What is the all time high annual FCF for Aerie Pharmaceuticals?
Aerie Pharmaceuticals all-time high annual free cash flow is -$12.05 M
What is Aerie Pharmaceuticals annual FCF year-on-year change?
Over the past year, AERI annual free cash flow has changed by -$34.66 M (-51.12%)
What is Aerie Pharmaceuticals quarterly free cash flow?
The current quarterly FCF of AERI is -$12.21 M
What is the all time high quarterly FCF for Aerie Pharmaceuticals?
Aerie Pharmaceuticals all-time high quarterly free cash flow is $60.31 M
What is Aerie Pharmaceuticals quarterly FCF year-on-year change?
Over the past year, AERI quarterly free cash flow has changed by +$7.80 M (+38.97%)
What is Aerie Pharmaceuticals TTM free cash flow?
The current TTM FCF of AERI is $2.64 M
What is the all time high TTM FCF for Aerie Pharmaceuticals?
Aerie Pharmaceuticals all-time high TTM free cash flow is $2.64 M
What is Aerie Pharmaceuticals TTM FCF year-on-year change?
Over the past year, AERI TTM free cash flow has changed by +$52.45 M (+105.29%)